

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.83814419 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 5.83814419 |
| 3 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.78294227 |
| 4 | tryptophan catabolic process (GO:0006569) | 5.77311008 |
| 5 | indole-containing compound catabolic process (GO:0042436) | 5.77311008 |
| 6 | indolalkylamine catabolic process (GO:0046218) | 5.77311008 |
| 7 | tryptophan metabolic process (GO:0006568) | 5.73382817 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.72776055 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.43396464 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.43396464 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 5.29648119 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.20547965 |
| 13 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95858933 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 4.95747040 |
| 15 | complement activation, alternative pathway (GO:0006957) | 4.87478539 |
| 16 | bile acid biosynthetic process (GO:0006699) | 4.83682514 |
| 17 | thrombin receptor signaling pathway (GO:0070493) | 4.83279413 |
| 18 | protein neddylation (GO:0045116) | 4.69625183 |
| 19 | urea metabolic process (GO:0019627) | 4.62716717 |
| 20 | urea cycle (GO:0000050) | 4.62716717 |
| 21 | reverse cholesterol transport (GO:0043691) | 4.61568781 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 4.49959591 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.49761718 |
| 24 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 4.47726309 |
| 25 | glyoxylate metabolic process (GO:0046487) | 4.45893916 |
| 26 | phospholipid efflux (GO:0033700) | 4.44823165 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.44278003 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39937795 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 4.39937795 |
| 30 | macromolecular complex remodeling (GO:0034367) | 4.39937795 |
| 31 | amine catabolic process (GO:0009310) | 4.38639460 |
| 32 | cellular biogenic amine catabolic process (GO:0042402) | 4.38639460 |
| 33 | indolalkylamine metabolic process (GO:0006586) | 4.33878470 |
| 34 | tyrosine metabolic process (GO:0006570) | 4.32580697 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.31722579 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28433990 |
| 37 | protein carboxylation (GO:0018214) | 4.28433990 |
| 38 | regulation of complement activation (GO:0030449) | 4.25033951 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.17447068 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 4.12310732 |
| 41 | synaptic vesicle maturation (GO:0016188) | 4.11941171 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.09734527 |
| 43 | bile acid metabolic process (GO:0008206) | 4.07617749 |
| 44 | positive regulation of steroid hormone secretion (GO:2000833) | 4.05811441 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 4.04708851 |
| 46 | detection of bacterium (GO:0016045) | 4.04339029 |
| 47 | plasma lipoprotein particle clearance (GO:0034381) | 4.03998217 |
| 48 | acylglycerol homeostasis (GO:0055090) | 3.99620432 |
| 49 | triglyceride homeostasis (GO:0070328) | 3.99620432 |
| 50 | cholesterol efflux (GO:0033344) | 3.94738452 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 3.94307555 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 3.92652879 |
| 53 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.92622394 |
| 54 | regulation of fibrinolysis (GO:0051917) | 3.89665033 |
| 55 | negative regulation of fibrinolysis (GO:0051918) | 3.86677366 |
| 56 | coenzyme catabolic process (GO:0009109) | 3.85737342 |
| 57 | cellular glucuronidation (GO:0052695) | 3.80679346 |
| 58 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.77619581 |
| 59 | phospholipid homeostasis (GO:0055091) | 3.76998737 |
| 60 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74068851 |
| 61 | detection of other organism (GO:0098543) | 3.73697020 |
| 62 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.73587969 |
| 63 | adenosine metabolic process (GO:0046085) | 3.69828470 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 3.67487770 |
| 65 | negative regulation of sterol transport (GO:0032372) | 3.67487770 |
| 66 | linoleic acid metabolic process (GO:0043651) | 3.67159359 |
| 67 | NAD biosynthetic process (GO:0009435) | 3.62440537 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 3.61503913 |
| 69 | negative regulation of lipase activity (GO:0060192) | 3.61253473 |
| 70 | alpha-amino acid catabolic process (GO:1901606) | 3.59578330 |
| 71 | cytolysis (GO:0019835) | 3.58995209 |
| 72 | regulation of platelet aggregation (GO:0090330) | 3.56757998 |
| 73 | behavioral response to cocaine (GO:0048148) | 3.56241825 |
| 74 | regulation of sensory perception of pain (GO:0051930) | 3.55812924 |
| 75 | regulation of sensory perception (GO:0051931) | 3.55812924 |
| 76 | homocysteine metabolic process (GO:0050667) | 3.54559376 |
| 77 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.52508180 |
| 78 | plasma lipoprotein particle organization (GO:0071827) | 3.52191811 |
| 79 | carnitine metabolic process (GO:0009437) | 3.51551412 |
| 80 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.49082732 |
| 81 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.49082732 |
| 82 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.47316494 |
| 83 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.47165388 |
| 84 | positive regulation of lipid catabolic process (GO:0050996) | 3.44938547 |
| 85 | serine family amino acid catabolic process (GO:0009071) | 3.44018195 |
| 86 | beta-amyloid metabolic process (GO:0050435) | 3.44005622 |
| 87 | adaptation of signaling pathway (GO:0023058) | 3.40247053 |
| 88 | bile acid and bile salt transport (GO:0015721) | 3.38650575 |
| 89 | uronic acid metabolic process (GO:0006063) | 3.36595569 |
| 90 | glucuronate metabolic process (GO:0019585) | 3.36595569 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.35484813 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.35484813 |
| 93 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.33924437 |
| 94 | ketone body metabolic process (GO:1902224) | 3.33730371 |
| 95 | cysteine metabolic process (GO:0006534) | 3.33347287 |
| 96 | negative regulation of norepinephrine secretion (GO:0010700) | 3.32785061 |
| 97 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.30029820 |
| 98 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.30029820 |
| 99 | complement activation (GO:0006956) | 3.29821722 |
| 100 | complement activation, classical pathway (GO:0006958) | 3.29411922 |
| 101 | cofactor catabolic process (GO:0051187) | 3.28971230 |
| 102 | cellular amino acid catabolic process (GO:0009063) | 3.28892010 |
| 103 | negative regulation of heart rate (GO:0010459) | 3.26087923 |
| 104 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.24205752 |
| 105 | fatty acid beta-oxidation (GO:0006635) | 3.23206295 |
| 106 | benzene-containing compound metabolic process (GO:0042537) | 3.22735862 |
| 107 | lysine metabolic process (GO:0006553) | 3.22546321 |
| 108 | lysine catabolic process (GO:0006554) | 3.22546321 |
| 109 | protein activation cascade (GO:0072376) | 3.22214384 |
| 110 | aldehyde catabolic process (GO:0046185) | 3.21587507 |
| 111 | protein-lipid complex subunit organization (GO:0071825) | 3.21057685 |
| 112 | blood coagulation, intrinsic pathway (GO:0007597) | 3.20480982 |
| 113 | regulation of female receptivity (GO:0045924) | 3.20258157 |
| 114 | arginine metabolic process (GO:0006525) | 3.16651321 |
| 115 | fibrinolysis (GO:0042730) | 3.15941899 |
| 116 | regulation of platelet activation (GO:0010543) | 3.13483593 |
| 117 | imidazole-containing compound metabolic process (GO:0052803) | 3.13255821 |
| 118 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.12346771 |
| 119 | fatty acid oxidation (GO:0019395) | 3.10936726 |
| 120 | lipid oxidation (GO:0034440) | 3.09480055 |
| 121 | cellular modified amino acid catabolic process (GO:0042219) | 3.07912278 |
| 122 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 3.07642152 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.06849350 |
| 124 | monocarboxylic acid catabolic process (GO:0072329) | 3.05618028 |
| 125 | auditory receptor cell differentiation (GO:0042491) | 3.00899141 |
| 126 | negative regulation of protein localization to cell surface (GO:2000009) | 3.00566635 |
| 127 | biotin metabolic process (GO:0006768) | 2.99272091 |
| 128 | neutrophil activation involved in immune response (GO:0002283) | 2.96385206 |
| 129 | regulation of lipoprotein metabolic process (GO:0050746) | 2.93286830 |
| 130 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.92187527 |
| 131 | DNA methylation involved in gamete generation (GO:0043046) | 2.90063957 |
| 132 | positive regulation of neurotransmitter transport (GO:0051590) | 2.88378552 |
| 133 | polyamine biosynthetic process (GO:0006596) | 2.86732761 |
| 134 | vesicle docking involved in exocytosis (GO:0006904) | 2.85127059 |
| 135 | dopamine transport (GO:0015872) | 2.84748485 |
| 136 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.84662159 |
| 137 | regulation of norepinephrine secretion (GO:0014061) | 2.83458041 |
| 138 | regulation of response to food (GO:0032095) | 2.82026089 |
| 139 | negative regulation of appetite (GO:0032099) | 2.80878943 |
| 140 | negative regulation of response to food (GO:0032096) | 2.80878943 |
| 141 | pharyngeal system development (GO:0060037) | 2.79401066 |
| 142 | negative regulation of catecholamine secretion (GO:0033604) | 2.76916745 |
| 143 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.75716913 |
| 144 | positive regulation of mast cell activation (GO:0033005) | 2.74806103 |
| 145 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.73694768 |
| 146 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.73369386 |
| 147 | relaxation of smooth muscle (GO:0044557) | 2.72389137 |
| 148 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.70129597 |
| 149 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.69334193 |
| 150 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.68244913 |
| 151 | serotonin metabolic process (GO:0042428) | 2.66495859 |
| 152 | calcium ion import (GO:0070509) | 2.63770790 |
| 153 | termination of signal transduction (GO:0023021) | 2.62628246 |
| 154 | lipoxygenase pathway (GO:0019372) | 2.62215587 |
| 155 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.61775208 |
| 156 | negative regulation of platelet activation (GO:0010544) | 2.61588324 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.60292643 |
| 158 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.60029473 |
| 159 | amine biosynthetic process (GO:0009309) | 2.59856595 |
| 160 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.58925510 |
| 161 | regulation of steroid hormone secretion (GO:2000831) | 2.58474797 |
| 162 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.57868353 |
| 163 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.57696620 |
| 164 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.57576843 |
| 165 | adenosine receptor signaling pathway (GO:0001973) | 2.57329159 |
| 166 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.55752468 |
| 167 | tachykinin receptor signaling pathway (GO:0007217) | 2.55530552 |
| 168 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.54685332 |
| 169 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.53939713 |
| 170 | import into cell (GO:0098657) | 2.53554974 |
| 171 | behavioral response to nicotine (GO:0035095) | 2.53001614 |
| 172 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.50766075 |
| 173 | negative regulation of heart contraction (GO:0045822) | 2.50242980 |
| 174 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.50011641 |
| 175 | monoamine transport (GO:0015844) | 2.49412250 |
| 176 | female mating behavior (GO:0060180) | 2.48012613 |
| 177 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.47107901 |
| 178 | mitotic cell cycle arrest (GO:0071850) | 2.46218992 |
| 179 | detection of temperature stimulus (GO:0016048) | 2.45102707 |
| 180 | piRNA metabolic process (GO:0034587) | 2.44832324 |
| 181 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.42868749 |
| 182 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.42515990 |
| 183 | detection of light stimulus involved in visual perception (GO:0050908) | 2.42515990 |
| 184 | neuronal action potential propagation (GO:0019227) | 2.42334472 |
| 185 | platelet aggregation (GO:0070527) | 2.41800339 |
| 186 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.38432669 |
| 187 | regulation of glutamate secretion (GO:0014048) | 2.37860864 |
| 188 | fatty acid transmembrane transport (GO:1902001) | 2.35583653 |
| 189 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.35016644 |
| 190 | vesicle docking (GO:0048278) | 2.34250752 |
| 191 | regulation of memory T cell differentiation (GO:0043380) | 2.32376274 |
| 192 | artery development (GO:0060840) | 2.32198487 |
| 193 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.31264788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.15750712 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.47683969 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.45873974 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.10700097 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.58321297 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.43534202 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.55017602 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.19890433 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.08201197 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.97243689 |
| 11 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.87045813 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.68815982 |
| 13 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.66178460 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.62754204 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.44988178 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.32664412 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.32062911 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28930767 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.21822640 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17531922 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10068957 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02972614 |
| 23 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97627812 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95633311 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.89214678 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88655067 |
| 27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.81775765 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79583302 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75405520 |
| 30 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.73391568 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.65866007 |
| 32 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61552971 |
| 33 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53425785 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.53126241 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.52765133 |
| 36 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48331279 |
| 37 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.47777572 |
| 38 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47547957 |
| 39 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.42761222 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41911210 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39574281 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.37974156 |
| 43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35695814 |
| 44 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.35205930 |
| 45 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.35057222 |
| 46 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34754398 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.34504130 |
| 48 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.32506174 |
| 49 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31310382 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31310382 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30448827 |
| 52 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.30186463 |
| 53 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28931088 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.28630762 |
| 55 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27614807 |
| 56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27061557 |
| 57 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27032746 |
| 58 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.26754106 |
| 59 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25919214 |
| 60 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.25055560 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23461212 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.23281440 |
| 63 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.22389720 |
| 64 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.22195155 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.22024794 |
| 66 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21559361 |
| 67 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.20893481 |
| 68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.20424307 |
| 69 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19658106 |
| 70 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18942028 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.18927717 |
| 72 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.18871664 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18481379 |
| 74 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18416218 |
| 75 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18048673 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17549769 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17174169 |
| 78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16251678 |
| 79 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.16177236 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15785933 |
| 81 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14785112 |
| 82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14192312 |
| 83 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.14185212 |
| 84 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13162330 |
| 85 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.12448248 |
| 86 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.11743658 |
| 87 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.11445014 |
| 88 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11249220 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11012584 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.10289515 |
| 91 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.10271769 |
| 92 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09366648 |
| 93 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.09247346 |
| 94 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08613294 |
| 95 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08557952 |
| 96 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.07714850 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07658297 |
| 98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07310900 |
| 99 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06704501 |
| 100 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06606381 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06358420 |
| 102 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.05302124 |
| 103 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.04696208 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04202497 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04170447 |
| 106 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04054594 |
| 107 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03308131 |
| 108 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03228762 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.02865236 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01034394 |
| 111 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00518521 |
| 112 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99999701 |
| 113 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99522080 |
| 114 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.99375315 |
| 115 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.99365583 |
| 116 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99123199 |
| 117 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.98587826 |
| 118 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.98194745 |
| 119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.97187483 |
| 120 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97105862 |
| 121 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96689993 |
| 122 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96490964 |
| 123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95196589 |
| 124 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94466708 |
| 125 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93576633 |
| 126 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.92612475 |
| 127 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.92596830 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92474835 |
| 129 | AR_20517297_ChIP-Seq_VCAP_Human | 0.92145962 |
| 130 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91434987 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91024596 |
| 132 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.90711534 |
| 133 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90507671 |
| 134 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90199725 |
| 135 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.88974623 |
| 136 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88764385 |
| 137 | AR_19668381_ChIP-Seq_PC3_Human | 0.88030783 |
| 138 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87796325 |
| 139 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.87681617 |
| 140 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87012143 |
| 141 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86760122 |
| 142 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.86712190 |
| 143 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.86092133 |
| 144 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.85958610 |
| 145 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85794378 |
| 146 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85727866 |
| 147 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.85073258 |
| 148 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84683104 |
| 149 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.84671090 |
| 150 | SPI1_23127762_ChIP-Seq_K562_Human | 0.84408101 |
| 151 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82555668 |
| 152 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.81153589 |
| 153 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.80922121 |
| 154 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79223615 |
| 155 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79028883 |
| 156 | STAT3_23295773_ChIP-Seq_U87_Human | 0.75468466 |
| 157 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75340095 |
| 158 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.74572723 |
| 159 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.74572723 |
| 160 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.74281470 |
| 161 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74157149 |
| 162 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73526711 |
| 163 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.72779612 |
| 164 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72577516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.71969869 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 5.88507693 |
| 3 | MP0005360_urolithiasis | 5.80565986 |
| 4 | MP0005365_abnormal_bile_salt | 5.72080219 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.70959963 |
| 6 | MP0003252_abnormal_bile_duct | 3.60014675 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.37755962 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 3.28796122 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.26992709 |
| 10 | MP0002876_abnormal_thyroid_physiology | 3.19189820 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.10014817 |
| 12 | MP0009697_abnormal_copulation | 2.98371184 |
| 13 | MP0003879_abnormal_hair_cell | 2.88634590 |
| 14 | MP0008004_abnormal_stomach_pH | 2.80164430 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.76284425 |
| 16 | MP0006276_abnormal_autonomic_nervous | 2.72321259 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.69860991 |
| 18 | MP0009840_abnormal_foam_cell | 2.66079893 |
| 19 | MP0005310_abnormal_salivary_gland | 2.62007374 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.44795459 |
| 21 | MP0003195_calcinosis | 2.38312201 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.37531797 |
| 23 | MP0002822_catalepsy | 2.32708645 |
| 24 | MP0004510_myositis | 2.20192004 |
| 25 | MP0005332_abnormal_amino_acid | 2.19248295 |
| 26 | MP0001666_abnormal_nutrient_absorption | 2.18572992 |
| 27 | MP0000230_abnormal_systemic_arterial | 2.06382846 |
| 28 | MP0004859_abnormal_synaptic_plasticity | 2.06063761 |
| 29 | MP0002733_abnormal_thermal_nociception | 2.05290903 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 2.04694390 |
| 31 | MP0000609_abnormal_liver_physiology | 2.03130009 |
| 32 | MP0005551_abnormal_eye_electrophysiolog | 2.01195987 |
| 33 | MP0005083_abnormal_biliary_tract | 1.97039235 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.96906560 |
| 35 | MP0001764_abnormal_homeostasis | 1.95371167 |
| 36 | MP0003880_abnormal_central_pattern | 1.93951665 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.93156247 |
| 38 | MP0001970_abnormal_pain_threshold | 1.88269047 |
| 39 | MP0002272_abnormal_nervous_system | 1.87950072 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.76884947 |
| 41 | MP0001486_abnormal_startle_reflex | 1.74758243 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.74564168 |
| 43 | MP0009745_abnormal_behavioral_response | 1.72203372 |
| 44 | MP0003868_abnormal_feces_composition | 1.71534524 |
| 45 | MP0001664_abnormal_digestion | 1.70042960 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.69280348 |
| 47 | * MP0003635_abnormal_synaptic_transmissio | 1.68188494 |
| 48 | MP0009046_muscle_twitch | 1.67211786 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.63696171 |
| 50 | MP0008872_abnormal_physiological_respon | 1.61086513 |
| 51 | MP0001765_abnormal_ion_homeostasis | 1.56794613 |
| 52 | MP0002063_abnormal_learning/memory/cond | 1.53901034 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.52317586 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.51011564 |
| 55 | MP0005647_abnormal_sex_gland | 1.50469825 |
| 56 | MP0009764_decreased_sensitivity_to | 1.49213946 |
| 57 | MP0008775_abnormal_heart_ventricle | 1.49094198 |
| 58 | MP0002064_seizures | 1.48308589 |
| 59 | MP0005670_abnormal_white_adipose | 1.47936508 |
| 60 | MP0002572_abnormal_emotion/affect_behav | 1.44862061 |
| 61 | MP0004036_abnormal_muscle_relaxation | 1.41866027 |
| 62 | MP0001835_abnormal_antigen_presentation | 1.40684939 |
| 63 | MP0002067_abnormal_sensory_capabilities | 1.39401304 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.37622919 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.34194258 |
| 66 | MP0001756_abnormal_urination | 1.33202889 |
| 67 | MP0003787_abnormal_imprinting | 1.32269512 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32269353 |
| 69 | MP0003690_abnormal_glial_cell | 1.29600799 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.27021747 |
| 71 | MP0003186_abnormal_redox_activity | 1.26872726 |
| 72 | MP0002909_abnormal_adrenal_gland | 1.24260665 |
| 73 | MP0003656_abnormal_erythrocyte_physiolo | 1.24008711 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.21887439 |
| 75 | MP0004085_abnormal_heartbeat | 1.21401336 |
| 76 | MP0004270_analgesia | 1.21337655 |
| 77 | MP0002254_reproductive_system_inflammat | 1.19007736 |
| 78 | MP0004084_abnormal_cardiac_muscle | 1.17198920 |
| 79 | MP0003633_abnormal_nervous_system | 1.17025972 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 1.16664416 |
| 81 | MP0008469_abnormal_protein_level | 1.15058040 |
| 82 | MP0003436_decreased_susceptibility_to | 1.14344060 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 1.13965303 |
| 84 | MP0004147_increased_porphyrin_level | 1.13762139 |
| 85 | MP0005451_abnormal_body_composition | 1.13548832 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.10994086 |
| 87 | MP0009785_altered_susceptibility_to | 1.10919667 |
| 88 | MP0002419_abnormal_innate_immunity | 1.10888011 |
| 89 | MP0005253_abnormal_eye_physiology | 1.10842033 |
| 90 | MP0002693_abnormal_pancreas_physiology | 1.06019074 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 1.04141904 |
| 92 | MP0002090_abnormal_vision | 1.03963354 |
| 93 | MP0009763_increased_sensitivity_to | 1.03296347 |
| 94 | MP0005410_abnormal_fertilization | 1.02428307 |
| 95 | MP0002653_abnormal_ependyma_morphology | 1.02129830 |
| 96 | MP0003122_maternal_imprinting | 0.99286307 |
| 97 | MP0004043_abnormal_pH_regulation | 0.98862043 |
| 98 | MP0004130_abnormal_muscle_cell | 0.97819224 |
| 99 | MP0001853_heart_inflammation | 0.96778814 |
| 100 | MP0000598_abnormal_liver_morphology | 0.95178183 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.94682981 |
| 102 | MP0005535_abnormal_body_temperature | 0.93228331 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.93090341 |
| 104 | MP0001984_abnormal_olfaction | 0.91756287 |
| 105 | MP0003045_fibrosis | 0.91377553 |
| 106 | MP0003638_abnormal_response/metabolism_ | 0.91233671 |
| 107 | MP0002229_neurodegeneration | 0.90635631 |
| 108 | MP0005334_abnormal_fat_pad | 0.87996062 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.87457003 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.86627468 |
| 111 | MP0003631_nervous_system_phenotype | 0.85331749 |
| 112 | MP0006082_CNS_inflammation | 0.85037064 |
| 113 | MP0009642_abnormal_blood_homeostasis | 0.84636016 |
| 114 | MP0005387_immune_system_phenotype | 0.84600460 |
| 115 | MP0001790_abnormal_immune_system | 0.84600460 |
| 116 | MP0002009_preneoplasia | 0.84404253 |
| 117 | MP0009643_abnormal_urine_homeostasis | 0.84162041 |
| 118 | MP0008877_abnormal_DNA_methylation | 0.83292371 |
| 119 | MP0004142_abnormal_muscle_tone | 0.83077244 |
| 120 | MP0005376_homeostasis/metabolism_phenot | 0.82027167 |
| 121 | MP0002638_abnormal_pupillary_reflex | 0.81220071 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.80654731 |
| 123 | MP0005166_decreased_susceptibility_to | 0.79394603 |
| 124 | MP0002102_abnormal_ear_morphology | 0.78698011 |
| 125 | MP0004742_abnormal_vestibular_system | 0.77279278 |
| 126 | MP0002928_abnormal_bile_duct | 0.76865768 |
| 127 | MP0002148_abnormal_hypersensitivity_rea | 0.76059183 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.75117774 |
| 129 | MP0005423_abnormal_somatic_nervous | 0.74353620 |
| 130 | MP0001502_abnormal_circadian_rhythm | 0.73643554 |
| 131 | MP0000015_abnormal_ear_pigmentation | 0.73582297 |
| 132 | MP0000604_amyloidosis | 0.73014247 |
| 133 | MP0001905_abnormal_dopamine_level | 0.70908122 |
| 134 | MP0002132_abnormal_respiratory_system | 0.70869083 |
| 135 | MP0006036_abnormal_mitochondrial_physio | 0.70560572 |
| 136 | MP0000372_irregular_coat_pigmentation | 0.70525217 |
| 137 | MP0005025_abnormal_response_to | 0.70460139 |
| 138 | MP0003950_abnormal_plasma_membrane | 0.70145181 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.69363954 |
| 140 | MP0006072_abnormal_retinal_apoptosis | 0.69322889 |
| 141 | MP0005058_abnormal_lysosome_morphology | 0.68102291 |
| 142 | MP0001963_abnormal_hearing_physiology | 0.67600772 |
| 143 | MP0004782_abnormal_surfactant_physiolog | 0.67191619 |
| 144 | MP0000681_abnormal_thyroid_gland | 0.66801892 |
| 145 | MP0005448_abnormal_energy_balance | 0.66764129 |
| 146 | MP0001845_abnormal_inflammatory_respons | 0.66674426 |
| 147 | MP0003698_abnormal_male_reproductive | 0.66190486 |
| 148 | MP0004811_abnormal_neuron_physiology | 0.66028702 |
| 149 | MP0001879_abnormal_lymphatic_vessel | 0.65914092 |
| 150 | MP0005671_abnormal_response_to | 0.65545870 |
| 151 | MP0003011_delayed_dark_adaptation | 0.65205296 |
| 152 | MP0000371_diluted_coat_color | 0.65159429 |
| 153 | MP0003718_maternal_effect | 0.64999480 |
| 154 | MP0002971_abnormal_brown_adipose | 0.64384946 |
| 155 | MP0001663_abnormal_digestive_system | 0.63483010 |
| 156 | MP0000516_abnormal_urinary_system | 0.62907763 |
| 157 | MP0005367_renal/urinary_system_phenotyp | 0.62907763 |
| 158 | MP0003724_increased_susceptibility_to | 0.62473034 |
| 159 | MP0004883_abnormal_blood_vessel | 0.61689332 |
| 160 | MP0004381_abnormal_hair_follicle | 0.60646429 |
| 161 | MP0005171_absent_coat_pigmentation | 0.60473244 |
| 162 | MP0003075_altered_response_to | 0.60328818 |
| 163 | MP0001800_abnormal_humoral_immune | 0.59519058 |
| 164 | MP0005636_abnormal_mineral_homeostasis | 0.55741406 |
| 165 | MP0001661_extended_life_span | 0.55739327 |
| 166 | MP0008260_abnormal_autophagy | 0.54989014 |
| 167 | MP0005164_abnormal_response_to | 0.54391316 |
| 168 | MP0003943_abnormal_hepatobiliary_system | 0.53901653 |
| 169 | MP0002452_abnormal_antigen_presenting | 0.51627624 |
| 170 | MP0005075_abnormal_melanosome_morpholog | 0.51414260 |
| 171 | MP0005408_hypopigmentation | 0.51254716 |
| 172 | MP0000427_abnormal_hair_cycle | 0.49700533 |
| 173 | MP0003953_abnormal_hormone_level | 0.49148263 |
| 174 | MP0003172_abnormal_lysosome_physiology | 0.48975846 |
| 175 | MP0002723_abnormal_immune_serum | 0.48804726 |
| 176 | MP0005187_abnormal_penis_morphology | 0.46239332 |
| 177 | MP0009115_abnormal_fat_cell | 0.45894124 |
| 178 | MP0002736_abnormal_nociception_after | 0.45076394 |
| 179 | MP0005666_abnormal_adipose_tissue | 0.43374469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged bleeding time (HP:0003010) | 7.46621175 |
| 2 | Increased mean platelet volume (HP:0011877) | 7.04488145 |
| 3 | Abnormal platelet volume (HP:0011876) | 6.44313506 |
| 4 | Petechiae (HP:0000967) | 6.15991966 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.92292959 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.84067213 |
| 7 | Purpura (HP:0000979) | 5.48419964 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.48232250 |
| 9 | Deep venous thrombosis (HP:0002625) | 5.33719879 |
| 10 | Complement deficiency (HP:0004431) | 5.33196974 |
| 11 | Xanthomatosis (HP:0000991) | 5.23531259 |
| 12 | Hyperlipoproteinemia (HP:0010980) | 4.97171520 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.90457069 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.76979159 |
| 15 | Hypobetalipoproteinemia (HP:0003563) | 4.74178422 |
| 16 | Joint hemorrhage (HP:0005261) | 4.60631106 |
| 17 | Epistaxis (HP:0000421) | 4.57262922 |
| 18 | Myokymia (HP:0002411) | 4.33124113 |
| 19 | Epidermoid cyst (HP:0200040) | 4.03527399 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.94068186 |
| 21 | Abnormality of complement system (HP:0005339) | 3.87192487 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.69675826 |
| 23 | Gaze-evoked nystagmus (HP:0000640) | 3.69056650 |
| 24 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.64753765 |
| 25 | Hyperammonemia (HP:0001987) | 3.63116207 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.61953634 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.56647561 |
| 28 | Decreased central vision (HP:0007663) | 3.53877909 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.53510027 |
| 30 | Hypoalphalipoproteinemia (HP:0003233) | 3.48564887 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 3.48492670 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.43948029 |
| 33 | Fat malabsorption (HP:0002630) | 3.41775760 |
| 34 | Ketosis (HP:0001946) | 3.41304840 |
| 35 | Short 1st metacarpal (HP:0010034) | 3.39294721 |
| 36 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.39294721 |
| 37 | Abnormality of methionine metabolism (HP:0010901) | 3.37284079 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37152646 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.35629623 |
| 40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33151490 |
| 41 | Impaired platelet aggregation (HP:0003540) | 3.31689773 |
| 42 | Abnormal platelet function (HP:0011869) | 3.31689773 |
| 43 | Febrile seizures (HP:0002373) | 3.31582504 |
| 44 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.26162702 |
| 45 | Genetic anticipation (HP:0003743) | 3.24592262 |
| 46 | Abnormality of the 1st metacarpal (HP:0010009) | 3.24020694 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.18502558 |
| 48 | Hypochromic microcytic anemia (HP:0004840) | 3.16431676 |
| 49 | Renal cortical cysts (HP:0000803) | 3.14243710 |
| 50 | Poikilocytosis (HP:0004447) | 3.11646682 |
| 51 | Progressive cerebellar ataxia (HP:0002073) | 3.10754929 |
| 52 | Dyschromatopsia (HP:0007641) | 3.04917645 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.03979177 |
| 54 | Arthropathy (HP:0003040) | 3.01170082 |
| 55 | Sensorimotor neuropathy (HP:0007141) | 3.00782923 |
| 56 | Hyperglycinemia (HP:0002154) | 2.97974120 |
| 57 | Hypoglycemic seizures (HP:0002173) | 2.95597528 |
| 58 | Hyperglycinuria (HP:0003108) | 2.85906659 |
| 59 | Hypercholesterolemia (HP:0003124) | 2.84550935 |
| 60 | Acanthocytosis (HP:0001927) | 2.83013335 |
| 61 | Short phalanx of the thumb (HP:0009660) | 2.82650461 |
| 62 | Steatorrhea (HP:0002570) | 2.78632056 |
| 63 | Abnormal auditory evoked potentials (HP:0006958) | 2.71433943 |
| 64 | Focal seizures (HP:0007359) | 2.71425688 |
| 65 | Enlarged kidneys (HP:0000105) | 2.67340829 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67333624 |
| 67 | Abnormality of glycine metabolism (HP:0010895) | 2.67333624 |
| 68 | Focal motor seizures (HP:0011153) | 2.66431304 |
| 69 | Clumsiness (HP:0002312) | 2.65793809 |
| 70 | Hyperventilation (HP:0002883) | 2.58519522 |
| 71 | Amelogenesis imperfecta (HP:0000705) | 2.57387166 |
| 72 | Ketoacidosis (HP:0001993) | 2.56188140 |
| 73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.55563157 |
| 74 | Myocardial infarction (HP:0001658) | 2.54922364 |
| 75 | Fair hair (HP:0002286) | 2.53628860 |
| 76 | Hyperbilirubinemia (HP:0002904) | 2.51742622 |
| 77 | Metabolic acidosis (HP:0001942) | 2.49926972 |
| 78 | Vascular calcification (HP:0004934) | 2.48771252 |
| 79 | Bile duct proliferation (HP:0001408) | 2.48196359 |
| 80 | Abnormal biliary tract physiology (HP:0012439) | 2.48196359 |
| 81 | Neonatal hypoglycemia (HP:0001998) | 2.47700250 |
| 82 | Mitral stenosis (HP:0001718) | 2.47407512 |
| 83 | Spontaneous hematomas (HP:0007420) | 2.43875772 |
| 84 | Neoplasm of the heart (HP:0100544) | 2.38416051 |
| 85 | Gingival bleeding (HP:0000225) | 2.37908615 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.37297008 |
| 87 | Hepatocellular carcinoma (HP:0001402) | 2.30903292 |
| 88 | Hypophosphatemic rickets (HP:0004912) | 2.30278040 |
| 89 | Central scotoma (HP:0000603) | 2.29065208 |
| 90 | Attenuation of retinal blood vessels (HP:0007843) | 2.27991420 |
| 91 | Congenital stationary night blindness (HP:0007642) | 2.25512559 |
| 92 | Skin nodule (HP:0200036) | 2.25402951 |
| 93 | Abnormality of purine metabolism (HP:0004352) | 2.20263384 |
| 94 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.17174220 |
| 95 | Pancreatitis (HP:0001733) | 2.16529968 |
| 96 | Polyphagia (HP:0002591) | 2.16370205 |
| 97 | Bruising susceptibility (HP:0000978) | 2.16082437 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.15278857 |
| 99 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.14552269 |
| 100 | Impaired vibratory sensation (HP:0002495) | 2.14368356 |
| 101 | Epileptiform EEG discharges (HP:0011182) | 2.14044348 |
| 102 | Hypomagnesemia (HP:0002917) | 2.13653530 |
| 103 | Glomerulonephritis (HP:0000099) | 2.13428559 |
| 104 | Amyloidosis (HP:0011034) | 2.11677825 |
| 105 | Symptomatic seizures (HP:0011145) | 2.11282611 |
| 106 | EEG with generalized epileptiform discharges (HP:0011198) | 2.11144772 |
| 107 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.11133917 |
| 108 | Cardiovascular calcification (HP:0011915) | 2.09422654 |
| 109 | Proximal tubulopathy (HP:0000114) | 2.04972753 |
| 110 | Hypsarrhythmia (HP:0002521) | 2.04259657 |
| 111 | Choroideremia (HP:0001139) | 2.03888779 |
| 112 | Upper motor neuron abnormality (HP:0002127) | 2.02264496 |
| 113 | Hypoplasia of the thymus (HP:0000778) | 2.01840873 |
| 114 | Pigmentary retinal degeneration (HP:0001146) | 2.01331400 |
| 115 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.01080990 |
| 116 | Dicarboxylic aciduria (HP:0003215) | 2.01080990 |
| 117 | Generalized aminoaciduria (HP:0002909) | 2.00979304 |
| 118 | Recurrent bacterial skin infections (HP:0005406) | 2.00573556 |
| 119 | Dialeptic seizures (HP:0011146) | 1.99639453 |
| 120 | Thrombophlebitis (HP:0004418) | 1.98079025 |
| 121 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.97340449 |
| 122 | Opisthotonus (HP:0002179) | 1.96045038 |
| 123 | Osteomalacia (HP:0002749) | 1.95411104 |
| 124 | Tented upper lip vermilion (HP:0010804) | 1.94311303 |
| 125 | Delayed CNS myelination (HP:0002188) | 1.91998020 |
| 126 | Alveolar cell carcinoma (HP:0006519) | 1.91321115 |
| 127 | Submucous cleft hard palate (HP:0000176) | 1.90758179 |
| 128 | Retrobulbar optic neuritis (HP:0100654) | 1.90649776 |
| 129 | Optic neuritis (HP:0100653) | 1.90649776 |
| 130 | Decreased circulating renin level (HP:0003351) | 1.90132507 |
| 131 | Type II lissencephaly (HP:0007260) | 1.90030410 |
| 132 | Abnormality of binocular vision (HP:0011514) | 1.89891697 |
| 133 | Diplopia (HP:0000651) | 1.89891697 |
| 134 | Medial flaring of the eyebrow (HP:0010747) | 1.89527642 |
| 135 | Poor eye contact (HP:0000817) | 1.88583196 |
| 136 | Abnormal drinking behavior (HP:0030082) | 1.88033339 |
| 137 | Polydipsia (HP:0001959) | 1.88033339 |
| 138 | Testicular neoplasm (HP:0010788) | 1.87549673 |
| 139 | Thyroid-stimulating hormone excess (HP:0002925) | 1.87519474 |
| 140 | Elevated alkaline phosphatase (HP:0003155) | 1.85367604 |
| 141 | Absent speech (HP:0001344) | 1.85328405 |
| 142 | Orchitis (HP:0100796) | 1.85094049 |
| 143 | Pulmonary embolism (HP:0002204) | 1.85028912 |
| 144 | Rickets (HP:0002748) | 1.84558928 |
| 145 | Elevated hepatic transaminases (HP:0002910) | 1.84124587 |
| 146 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83308432 |
| 147 | Abnormal ciliary motility (HP:0012262) | 1.83042722 |
| 148 | Generalized hypopigmentation of hair (HP:0011358) | 1.82353539 |
| 149 | Acute hepatic failure (HP:0006554) | 1.81812403 |
| 150 | Joint swelling (HP:0001386) | 1.81569705 |
| 151 | Spontaneous abortion (HP:0005268) | 1.80343130 |
| 152 | Abnormal gallbladder physiology (HP:0012438) | 1.78641486 |
| 153 | Cholecystitis (HP:0001082) | 1.78641486 |
| 154 | Epileptic encephalopathy (HP:0200134) | 1.77788284 |
| 155 | Hyperthyroidism (HP:0000836) | 1.77261536 |
| 156 | Brushfield spots (HP:0001088) | 1.77018409 |
| 157 | Atonic seizures (HP:0010819) | 1.75489003 |
| 158 | Lethargy (HP:0001254) | 1.75397058 |
| 159 | Septate vagina (HP:0001153) | 1.74442856 |
| 160 | Abnormality of the renal cortex (HP:0011035) | 1.73353109 |
| 161 | Abnormal gallbladder morphology (HP:0012437) | 1.73331222 |
| 162 | Ventricular fibrillation (HP:0001663) | 1.72440328 |
| 163 | Abnormal pupillary function (HP:0007686) | 1.72421158 |
| 164 | Absence seizures (HP:0002121) | 1.71617700 |
| 165 | Menorrhagia (HP:0000132) | 1.70394241 |
| 166 | Keratoconjunctivitis sicca (HP:0001097) | 1.69341791 |
| 167 | Delayed puberty (HP:0000823) | 1.68891211 |
| 168 | Gait imbalance (HP:0002141) | 1.68508735 |
| 169 | Broad-based gait (HP:0002136) | 1.67890110 |
| 170 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.65873201 |
| 171 | Absent/shortened dynein arms (HP:0200106) | 1.65873201 |
| 172 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.65555915 |
| 173 | Abnormality of secondary sexual hair (HP:0009888) | 1.65414011 |
| 174 | Abnormality of the axillary hair (HP:0100134) | 1.65414011 |
| 175 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.65312041 |
| 176 | Abnormality of alanine metabolism (HP:0010916) | 1.65312041 |
| 177 | Hyperalaninemia (HP:0003348) | 1.65312041 |
| 178 | Metabolic alkalosis (HP:0200114) | 1.64636353 |
| 179 | Visual hallucinations (HP:0002367) | 1.64306246 |
| 180 | Impaired smooth pursuit (HP:0007772) | 1.64279074 |
| 181 | Congenital sensorineural hearing impairment (HP:0008527) | 1.63089546 |
| 182 | Abnormality of magnesium homeostasis (HP:0004921) | 1.60824938 |
| 183 | Increased circulating renin level (HP:0000848) | 1.57654421 |
| 184 | Insidious onset (HP:0003587) | 1.55294123 |
| 185 | Termporal pattern (HP:0011008) | 1.55294123 |
| 186 | Calf muscle hypertrophy (HP:0008981) | 1.55163228 |
| 187 | Intellectual disability, profound (HP:0002187) | 1.54948022 |
| 188 | Agitation (HP:0000713) | 1.54744384 |
| 189 | Abolished electroretinogram (ERG) (HP:0000550) | 1.53806696 |
| 190 | Congenital primary aphakia (HP:0007707) | 1.53760327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMK1G | 4.85672809 |
| 2 | TAOK1 | 3.49536524 |
| 3 | BCKDK | 3.39805136 |
| 4 | INSRR | 3.29149997 |
| 5 | MAP3K14 | 3.18833009 |
| 6 | TNK2 | 3.14976991 |
| 7 | IRAK3 | 2.96101704 |
| 8 | CASK | 2.68878053 |
| 9 | IRAK4 | 2.50658305 |
| 10 | FRK | 2.45920989 |
| 11 | SIK3 | 2.14274482 |
| 12 | ERN1 | 1.99189679 |
| 13 | FGFR4 | 1.97476888 |
| 14 | SIK1 | 1.96373706 |
| 15 | TXK | 1.96290040 |
| 16 | ACVR1B | 1.95999335 |
| 17 | TYK2 | 1.93604039 |
| 18 | FER | 1.86493875 |
| 19 | SGK2 | 1.77878218 |
| 20 | PRKD2 | 1.73054087 |
| 21 | NEK9 | 1.72172174 |
| 22 | PRKD3 | 1.71049479 |
| 23 | TAOK3 | 1.69576946 |
| 24 | TBK1 | 1.64337537 |
| 25 | YES1 | 1.62708317 |
| 26 | CAMK1 | 1.61543571 |
| 27 | MARK2 | 1.59345370 |
| 28 | TNIK | 1.49665362 |
| 29 | FGFR2 | 1.46859235 |
| 30 | BMPR2 | 1.43826920 |
| 31 | BMX | 1.43685146 |
| 32 | PTK2B | 1.40891484 |
| 33 | PRPF4B | 1.40531572 |
| 34 | SGK3 | 1.37904836 |
| 35 | TRPM7 | 1.37817997 |
| 36 | TAOK2 | 1.37574615 |
| 37 | MAP2K4 | 1.35833943 |
| 38 | MAP2K3 | 1.34978121 |
| 39 | GRK5 | 1.34218904 |
| 40 | IKBKE | 1.33171249 |
| 41 | JAK1 | 1.31534266 |
| 42 | NUAK1 | 1.31431811 |
| 43 | NTRK3 | 1.26584677 |
| 44 | FGFR3 | 1.26405477 |
| 45 | MAPK7 | 1.25136428 |
| 46 | MINK1 | 1.24295324 |
| 47 | MAP2K7 | 1.23732576 |
| 48 | FLT3 | 1.23197205 |
| 49 | PIK3CG | 1.21996270 |
| 50 | MAP3K4 | 1.18980260 |
| 51 | PAK3 | 1.17981659 |
| 52 | ERBB3 | 1.17114037 |
| 53 | MYLK | 1.17042676 |
| 54 | IKBKB | 1.15476068 |
| 55 | ERBB4 | 1.12283080 |
| 56 | ZAK | 1.09447042 |
| 57 | EPHA4 | 1.08849685 |
| 58 | TEC | 1.07814315 |
| 59 | BMPR1B | 1.06815297 |
| 60 | KIT | 0.99844419 |
| 61 | MST4 | 0.99098576 |
| 62 | EPHA3 | 0.96376082 |
| 63 | AKT3 | 0.95906610 |
| 64 | RIPK4 | 0.95695907 |
| 65 | MAP2K6 | 0.95276389 |
| 66 | CSK | 0.92533630 |
| 67 | MAPK11 | 0.90788104 |
| 68 | OBSCN | 0.90568686 |
| 69 | SGK494 | 0.89236979 |
| 70 | SGK223 | 0.89236979 |
| 71 | MAP3K3 | 0.88442949 |
| 72 | MARK3 | 0.87665044 |
| 73 | PRKCI | 0.87627315 |
| 74 | EIF2AK2 | 0.87113466 |
| 75 | CAMKK2 | 0.86915454 |
| 76 | CDK6 | 0.83557774 |
| 77 | MELK | 0.82786395 |
| 78 | CSF1R | 0.82304748 |
| 79 | NLK | 0.82103114 |
| 80 | JAK2 | 0.81555192 |
| 81 | PIM2 | 0.81385643 |
| 82 | MAPK12 | 0.80695447 |
| 83 | ARAF | 0.79776546 |
| 84 | TGFBR2 | 0.78560348 |
| 85 | CHUK | 0.78262144 |
| 86 | PRKAA2 | 0.75541787 |
| 87 | WNK4 | 0.75395000 |
| 88 | PDK1 | 0.72882586 |
| 89 | IRAK1 | 0.71920550 |
| 90 | EIF2AK1 | 0.71211819 |
| 91 | LYN | 0.68418788 |
| 92 | PRKCQ | 0.65476998 |
| 93 | PNCK | 0.64542131 |
| 94 | SYK | 0.62497217 |
| 95 | DAPK3 | 0.61730185 |
| 96 | PASK | 0.60845552 |
| 97 | CAMKK1 | 0.60189627 |
| 98 | MAP3K11 | 0.59888077 |
| 99 | PRKCG | 0.59787104 |
| 100 | PRKAA1 | 0.58664140 |
| 101 | PRKD1 | 0.58543709 |
| 102 | MAPK4 | 0.58396781 |
| 103 | MAP4K1 | 0.57780701 |
| 104 | BTK | 0.57552570 |
| 105 | MAP3K5 | 0.56600308 |
| 106 | PRKCE | 0.55971092 |
| 107 | IGF1R | 0.54962947 |
| 108 | JAK3 | 0.53564728 |
| 109 | PRKCZ | 0.53096403 |
| 110 | ILK | 0.52708186 |
| 111 | IRAK2 | 0.52364698 |
| 112 | KSR1 | 0.51796694 |
| 113 | MAP4K2 | 0.51743676 |
| 114 | ADRBK1 | 0.50931338 |
| 115 | MAP3K7 | 0.50762761 |
| 116 | MARK1 | 0.50492761 |
| 117 | TLK1 | 0.50350740 |
| 118 | WNK3 | 0.50199876 |
| 119 | DAPK2 | 0.49812019 |
| 120 | ADRBK2 | 0.49799075 |
| 121 | PLK2 | 0.49365393 |
| 122 | PINK1 | 0.48889430 |
| 123 | PHKG1 | 0.48436485 |
| 124 | PHKG2 | 0.48436485 |
| 125 | SGK1 | 0.48200894 |
| 126 | ERBB2 | 0.48184543 |
| 127 | DAPK1 | 0.47669114 |
| 128 | PDPK1 | 0.46863501 |
| 129 | PIM1 | 0.45586124 |
| 130 | MAPKAPK3 | 0.45376135 |
| 131 | LMTK2 | 0.44858833 |
| 132 | ITK | 0.44343414 |
| 133 | GRK7 | 0.44202105 |
| 134 | CAMK1D | 0.43616218 |
| 135 | STK3 | 0.43609630 |
| 136 | STK39 | 0.43554458 |
| 137 | STK38L | 0.42749811 |
| 138 | STK10 | 0.42531173 |
| 139 | GRK1 | 0.42513996 |
| 140 | STK11 | 0.42422627 |
| 141 | BLK | 0.41513390 |
| 142 | MAP3K12 | 0.41045081 |
| 143 | PKN1 | 0.41038963 |
| 144 | MAPK13 | 0.40842699 |
| 145 | STK24 | 0.40529319 |
| 146 | HIPK2 | 0.40123732 |
| 147 | HCK | 0.39309105 |
| 148 | FGR | 0.37694659 |
| 149 | CDK3 | 0.36918020 |
| 150 | PRKACG | 0.36323231 |
| 151 | TIE1 | 0.36175946 |
| 152 | RET | 0.36133027 |
| 153 | CDK8 | 0.36100714 |
| 154 | PRKCA | 0.33756272 |
| 155 | CAMK2A | 0.33628625 |
| 156 | SIK2 | 0.33414307 |
| 157 | DYRK1A | 0.32538764 |
| 158 | PRKACA | 0.32412832 |
| 159 | PRKG1 | 0.31585066 |
| 160 | CAMK4 | 0.30484502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34608515 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.01052784 |
| 3 | Platelet activation_Homo sapiens_hsa04611 | 3.00786486 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.96521186 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.88488704 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.83620904 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.68121490 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.60119778 |
| 9 | Peroxisome_Homo sapiens_hsa04146 | 2.57012514 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.39473922 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37991340 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.37247802 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.29991383 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 2.28710479 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25414980 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.24240933 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.21540216 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19012343 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 2.12911324 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 2.10976305 |
| 21 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09034967 |
| 22 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 2.06967880 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06703840 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05567247 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.04060018 |
| 26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.03645880 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.91798646 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91592364 |
| 29 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87765046 |
| 30 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.86537941 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.84496950 |
| 32 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82689489 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.82510501 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80585854 |
| 35 | Insulin secretion_Homo sapiens_hsa04911 | 1.77589056 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73297635 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73122396 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66514038 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.66507928 |
| 40 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.66235827 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62652314 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60992652 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.60014112 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.59789683 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59422370 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 1.58750526 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.55944347 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.55922056 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.54797075 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.48024997 |
| 51 | Renin secretion_Homo sapiens_hsa04924 | 1.46175257 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.44163012 |
| 53 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43648650 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.41872974 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 1.39016689 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.37302385 |
| 57 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36998880 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36265784 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.35318481 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34649013 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.30216564 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29963835 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27472624 |
| 64 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.26963007 |
| 65 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.23900889 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.22411286 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 1.21330102 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.19613700 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 1.19348301 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16173074 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13680375 |
| 72 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11013755 |
| 73 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10536064 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.09743500 |
| 75 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09488826 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.08683832 |
| 77 | Lysine degradation_Homo sapiens_hsa00310 | 1.04787840 |
| 78 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.03646916 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02805521 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02374138 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.02344230 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01769376 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.01421922 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93995333 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91769808 |
| 86 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90773579 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89509725 |
| 88 | Alcoholism_Homo sapiens_hsa05034 | 0.88470084 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.88359015 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88305727 |
| 91 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88057750 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85972995 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82790501 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.81919252 |
| 95 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.80822813 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77525850 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75182599 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.73891771 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73482846 |
| 100 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73344307 |
| 101 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.69525328 |
| 102 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69286474 |
| 103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68278054 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67975994 |
| 105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67416996 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65206865 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61991725 |
| 108 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59491339 |
| 109 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58867894 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.58136784 |
| 111 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.57954042 |
| 112 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57447052 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56932295 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56827503 |
| 115 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.56525446 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54772688 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53468503 |
| 118 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52698611 |
| 119 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52147398 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51859274 |
| 121 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50410764 |
| 122 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46793220 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44915201 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.44855417 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44441909 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44421553 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43531048 |
| 128 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42961485 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41425019 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40771781 |
| 131 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40613285 |
| 132 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.40197195 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.39357481 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39259040 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.37872312 |
| 136 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37114538 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.36917459 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.36899642 |
| 139 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36563031 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35352521 |
| 141 | Glioma_Homo sapiens_hsa05214 | 0.34485723 |
| 142 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33648088 |
| 143 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33115557 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.32770236 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31724050 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30949059 |
| 147 | Insulin resistance_Homo sapiens_hsa04931 | 0.26920413 |
| 148 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.24265145 |
| 149 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.24154549 |
| 150 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23996798 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22466315 |
| 152 | Allograft rejection_Homo sapiens_hsa05330 | 0.22082622 |
| 153 | Leishmaniasis_Homo sapiens_hsa05140 | 0.21202317 |
| 154 | Pertussis_Homo sapiens_hsa05133 | 0.18568119 |
| 155 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.17577162 |
| 156 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.16935258 |
| 157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16623955 |
| 158 | Legionellosis_Homo sapiens_hsa05134 | 0.13591713 |
| 159 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.12307818 |
| 160 | Hepatitis C_Homo sapiens_hsa05160 | 0.11966410 |
| 161 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11770481 |
| 162 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.10186791 |
| 163 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.09771378 |
| 164 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.09081212 |
| 165 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.08304915 |
| 166 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07051670 |
| 167 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.03645895 |

